Maito, Alnaif A.

HRN: 21-35-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/13/2026
04/20/2026
PO
5ml
TID
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines